‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Ryan Cross

Senior Science Correspondent

On Tuesday, drug discoverer and biotech entrepreneur Alpha Lee told scientists at a chemistry meeting about a new molecule to combat the Zika virus. There …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Isomorphic Labs gets $600M from Thrive, GV and Alphabet

FDA's Peter Marks resigns, saying he won't accept Kennedy's 'misinformation and lies'

Vertex’s second-generation diabetes cell therapy fails early-stage study

Bluebird gets new M&A bid, seeking to top private equity offer

Exclusive: Transcend notches Phase 2 win to treat PTSD, invigorating budding neuroplastogen class

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others

‘Peo­ple will die’: End of NIH grants guts work be­tween aca­d­e­mics and com­pa­nies to counter next pan­dem­ic

Senior Science Correspondent

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic